AbCellera Biologics (ABCL) EBT (2020 - 2026)
AbCellera Biologics (ABCL) reported EBT of -$49.5 million for Q1 2026, up 6.51% on a YoY basis from -$46.5 million in Q1 2025, and down 154.05% quarter-over-quarter from -$19.5 million in Q4 2025.
AbCellera Biologics (ABCL) EBT (2020 - 2026) Analysis & Trends
AbCellera Biologics has reported EBT for 7 years, with the latest figure at -$49.5 million in Q1 2026.
- For the quarter ending Q1 2026, EBT rose 6.51% year-over-year to -$49.5 million; the trailing twelve-month figure through Mar 2026 stood at -$174.1 million (up 17.32% YoY), and the FY2025 full-year result was -$177.6 million, up 11.38% from the prior year.
- EBT for Q1 2026 stood at -$49.5 million, down from -$19.5 million in the prior quarter.
- The five-year high for EBT was $230.8 million in Q1 2022, with the low at -$68.8 million in Q3 2025.
- Historically, EBT has averaged -$21.3 million across 5 years, with a median of -$42.7 million in 2024.
- Annual changes were most pronounced in 2022 — EBT jumped 286.56% — and 2023, when it plunged 451.9%.
- AbCellera Biologics' EBT stood at -$31.4 million in 2022, then slumped by 54.72% to -$48.6 million in 2023, then rose by 3.65% to -$46.8 million in 2024, then soared by 58.36% to -$19.5 million in 2025, then slumped by 154.05% to -$49.5 million in 2026.
- The last three EBT figures came in at -$49.5 million (Q1 2026), -$19.5 million (Q4 2025), and -$68.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -15.31 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -3.18 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -56.48 Mn |
| 10 | AbCellera Biologics | 1.55 Bn | 1.44 Bn | - | -49.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.54 Mn |
| Dec 31, 2025 | -19.50 Mn |
| Sep 30, 2025 | -68.77 Mn |
| Jun 30, 2025 | -36.34 Mn |
| Mar 31, 2025 | -52.98 Mn |
| Dec 31, 2024 | -46.83 Mn |
| Sep 30, 2024 | -62.63 Mn |
| Jun 30, 2024 | -48.19 Mn |
| Mar 31, 2024 | -42.75 Mn |
| Dec 31, 2023 | -48.60 Mn |
| Sep 30, 2023 | -39.28 Mn |
| Jun 30, 2023 | -38.00 Mn |
| Mar 31, 2023 | -48.15 Mn |
| Dec 31, 2022 | -31.41 Mn |
| Sep 30, 2022 | 46.59 Mn |
| Jun 30, 2022 | -6.89 Mn |
| Mar 31, 2022 | 230.81 Mn |
| Dec 31, 2021 | 84.71 Mn |
| Sep 30, 2021 | -24.97 Mn |
| Jun 30, 2021 | -2.07 Mn |